Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXWASH: Dexamethasone vs Benzydamine Mouth Rinses for Prevention of Chemoradiotherapy-Associated Oral Mucositis in Head and Neck Cancer
2018-004078-89Phase 3Terminated
- Sponsor
- University of Turin, Department of Oncology
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in head and neck cancer (HNC) comparing Dexamethasone mouth rinse (Soldesam) with Benzydamine mouth rinse (Tantum Verde) (2 arms). Primary endpoint: Incidence of oral mucositis > grade 2 in oral cavity over 12 weeks. Started Jun 2021; status: terminated.
02
Drugs
dexamethasonebenzydamine
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on 2018-004078-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004078-89.